Peter Humaidan

ORCID: 0000-0001-6884-5366 · 51 papers in corpus
2021
Pathogens (Basel, Switzerland) ·doi:10.3390/pathogens10030295

Recent advances in molecular microbiology have enabled refined studies of the genital tract microbiota. This constitutes the basis of the present updated systematic review and meta-analysis which investigate vaginal dysbiosis (VD) as define…

2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00605-z

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Global…

2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00137

Introduction: It has recently been shown that late follicular phase progesterone levels correlate well with those in the early luteal phase, and that progesterone levels before and 12 h after human chorionic gonadotropin (hCG) administratio…

2020
BMJ open ·doi:10.1136/bmjopen-2019-035866

IntroductionRecent studies in in vitro fertilisation (IVF) patients have associated abnormal vaginal microbiota (AVM) with poor clinical pregnancy rates of 6%-9% per embryo transfer. The biological plausibility for this finding is hypothesi…

2020
BMJ (Clinical research ed.) ·doi:10.1136/bmj.m2519

ObjectiveTo compare the ongoing pregnancy rate between a freeze-all strategy and a fresh transfer strategy in assisted reproductive technology treatment.DesignMulticentre, randomised controlled superiority trial.SettingOutpatient fertility …

2020
Annals of clinical microbiology and antimicrobials ·doi:10.1186/s12941-020-00385-9
2020
BMJ open ·doi:10.1136/bmjopen-2019-032104

ObjectiveThe aim was to investigate the association between clinically significant uterine fibroids and preterm birth, caesarean section (CS), postpartum haemorrhage (PPH), placental abruption, intrauterine growth restriction (IUGR) and ute…

2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00221

Research question: Urine LH testing may be useful to confirm an LH surge after the GnRH agonist (GnRHa) trigger prior to oocyte retrieval in IVF. Design: A prospective cohort study, including oocyte donors undergoing ovarian stimulation, tr…

2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00067

Societal changes and the increasing desire and opportunity to preserve fertility have increased the demand for effective assisted reproductive technologies (ART) and have increased the range of scenarios in which ART is now used. In recent …

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00642

Objective: The POSEIDON criteria are used to stratify patients with low prognosis after assisted reproductive technology (ART) treatment. Since its introduction, there has been no large study about the prognosis of the POSEIDON population. …

review 2019
Panminerva medica ·doi:10.23736/S0031-0808.18.03492-4

Over the years concerns have arisen about possible adverse effects associated with controlled ovarian stimulation (COS) as regards not only the endometrium, but also on obstetrical and perinatal outcomes in pregnancies after fresh embryo tr…

2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00092

ObjectiveTo investigate whether mid-luteal serum progesterone (P4) exhibits significant fluctuations during a 12-h daytime period in women undergoing in vitro fertilization (IVF) and to explore whether the extent of these fluctuations could…

2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00193

ObjectiveTo identify follicle sizes on the day of trigger most likely to yield a mature oocyte following hCG, GnRH agonist (GnRHa), or kisspeptin during IVF treatment.DesignRetrospective analysis to determine the size of follicles on day of…

2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00690

Introduction: Corpus luteum (CL) produces progesterone (P4) and 17-OH progesterone (17-OH P4) during the luteal phase. Contrary to P4, 17-OH P4 is not supplied as part of the luteal phase support following IVF-treatment. Therefore, measurin…

2018
United European gastroenterology journal ·doi:10.1177/2050640618796750

BackgroundCoeliac disease is an autoimmune disease triggered by dietary gluten and has been associated with several conditions influencing female and male reproduction. Due to unspecific symptoms, coeliac disease can be unrecognised for yea…

2017
BMJ open ·doi:10.1136/bmjopen-2017-016106

IntroductionPregnancy rates after frozen embryo transfer (FET) have improved in recent years and are now approaching or even exceeding those obtained after fresh embryo transfer. This is partly due to improved laboratory techniques, but may…

2017
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dew360

Study questionHow does the efficacy and safety of a fixed-ratio combination of recombinant human FSH plus recombinant human LH (follitropin alfa plus lutropin alfa; r-hFSH/r-hLH) compare with that of r-hFSH monotherapy for controlled ovaria…

2015
BMJ open ·doi:10.1136/bmjopen-2015-008297

IntroductionThe results of a recent meta-analysis showed that adding recombinant human luteinising hormone (r-hLH) to recombinant human follicle-stimulating hormone (r-hFSH) for ovarian stimulation was beneficial in poor responders, resulti…

2014
Asian journal of andrology ·doi:10.4103/1008-682x.125398

It is well-documented that male overweight and obesity causes endocrine disorders that might diminish the male reproductive capacity; however, reports have been conflicting regarding the influence of male body mass index (BMI) on semen qual…

2013
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-11-51

BackgroundV-betaLH is a common genetic variant of LH caused by two polymorphic base changes in the beta subunit gene, altering the amino acid sequence (Trp8Arg and Ile15Thr). In a previous-preliminary trial performed in women undergoing IVF…

2013
Journal of ovarian research ·doi:10.1186/1757-2215-6-93

BackgroundConventional luteal support packages are inadequate to facilitate a fresh transfer after GnRH agonist (GnRHa) trigger in patients at high risk of developing ovarian hyperstimulation syndrome (OHSS). By providing intensive luteal-p…

2012
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-011-9704-8

PurposeThis study aimed to explore the incidence of empty follicle syndrome (EFS) in oocyte donors who had final oocyte maturation triggered with GnRHa and to compare the incidence of EFS in this group of patients with IVF patients who had …

2012
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-10-9

Variability in the subfertile patient population excludes the possibility of a single approach to controlled ovarian stimulation (COS) covering all the requirements of a patient. Modern technology has led to the development of new drugs, tr…

article 2012
·doi:10.1093/humrep/27.s2.45
2009
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-7-101

BackgroundWomen have been able to delay childbearing since effective contraception became available in the 1960s. However, fertility decreases with increasing maternal age. A slow but steady decrease in fertility is observed in women aged b…